InspireMD (NSPR) Gross Profit (2010 - 2025)

InspireMD's Gross Profit history runs 16 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• On a quarterly basis, Gross Profit rose 151.6% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 75.9% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 75.9% from the prior year.
• Gross Profit improved to $1.2 million in Q4 2025 per NSPR's latest filing, from $864000.0 in the prior quarter.
• Across five years, Gross Profit topped out at $1.2 million in Q4 2025 and bottomed at $92000.0 in Q3 2021.
• The 5-year median for Gross Profit is $348500.0 (2022), against an average of $391650.0.
• Biggest YoY gain for Gross Profit was 318.33% in 2021; the steepest drop was 69.13% in 2021.
• Year by year, Gross Profit stood at $294000.0 in 2021, then plunged by 32.65% to $198000.0 in 2022, then surged by 155.05% to $505000.0 in 2023, then decreased by 7.13% to $469000.0 in 2024, then soared by 151.6% to $1.2 million in 2025.
• Per Business Quant, the three latest NSPR Gross Profit figures stand at $1.2 million (Q4 2025), $864000.0 (Q3 2025), and $313000.0 (Q2 2025).